Hardest Working Board Members May 30, 2007
At the head of the list yet again is Richard Perkins, president and CEO of , who's on the boards of , Nortech Systems Inc., and Vital Images Inc. Although he seems to have cut back on his service, resigning from the board of PW Eagle and stepping away from CNS Inc. when it was sold to GlaxoSmithKline, he's actually just as busy as ever. "The way I've cut back is through attrition, just going down to four boards rather than six," he said. (Twin Cities Business Journal, MN)
SEC probing insider trading before CNS, Glaxo deal Oct 14, 2006
U.S. District Judge Eduardo Robreno for the Eastern District of Pennsylvania ordered that $655,000 in proceeds from the sale of CNS options be frozen and that the as yet to be identified purchasers appear in court on October 20, the SEC said. The trades were made in foreign omnibus accounts of U.S. broker-dealers in the names of Zurich Central Bank and Credit Suisse, the SEC said. (ABC News -- Wire)
GlaxoSmithKline agrees to buy CNS Oct 10, 2006
01:00 AMBEN HIRSCHLERREUTERS NEWS AGENCYLONDON GlaxoSmithKline PLC has agreed to buy United States consumer-health-care firm CNS Inc. for $566 million (U.S.) in cash, Europe's biggest drug maker says. The deal, which was announced yesterday, extends Glaxo's reach in the growing market for non-prescription health products. (Toronto Star)
GlaxoSmithKline buys CNS Inc. for $566M Oct 10, 2006
The price for CNS Inc., a Minneapolis company that also makes FiberChoice dietary fiber supplements, represents a premium of 31 percent over the trading price of CNS's common stock at close of business Friday. For the 12 months ended June 30, CNS sales of $118. (Washington Times, DC)
GlaxoSmithKline seeks approval to sell cancer drug Tykerb Oct 10, 2006
Glaxo, Europe's largest drug maker, also revealed it has agreed to buy CNS Inc., the U.S.-based manufacturer of Breathe Right nasal strips and FiberChoice fiber supplements, for around $566 million. The company has dual U.S. headquarters in Research Triangle Park, N.C. and Philadelphia. (Herald Sun)
GlaxoSmithKline to pay $566 million for CNS Inc. Oct 10, 2006
Glaxo to pay $566 mln for Breathe Right strips maker CNS - MarketWatch. Click the page icons. (MarketWatch)
Glaxo boosts consumer health with $566 million CNS buy Oct 10, 2006
LONDON GlaxoSmithKline Plc, Europe's biggest drugmaker, said on Monday it had agreed to pay $566 million in cash for U.S. consumer health firm CNS Inc.. The deal extends Glaxo's reach in the growing non-prescription healthcare market, which has seen a raft of mergers and acquisitions in recent years as companies seek increased economies of scale. (San Diego Union-Tribune -- Business)
Correction: Aug. 2 CNS Earnings Story Aug 5, 2006
(AP) - In a Aug. 2 story about CNS Inc.'s fiscal first-quarter earnings, The Associated Press reported erroneously that net income fell $3 ... MINNEAPOLIS (AP) -- CNS Inc. -- a marketer of personal care products including Breathe Right nasal strips and FiberChoice fiber supplements -- on Wednesday said fiscal first-quarter profit declined on higher advertising costs. (CNBC -- Research Alerts)
